Global CGT Network
Cell & Gene Therapy Solutions
Building the Foundation
for Next-Generation
Cell & Gene Therapy
Accelerating Cell & Gene Therapy through global expertise and innovation.
Cell & Gene Therapy
CAR-T Implementation
GMP Cell Processing Labs
Regenerative Medicine
Global Expertise
International specialist network
GMP & Regulatory
Compliant by design
Integrated Delivery
One coordinating partner
Clinically Ready
Built for operational go-live
Global CGT Network
Accelerating Cell & Gene Therapy Through Global Expertise & Innovation
From cell therapy and gene therapy programme development to CAR-T implementation, GMP cell processing laboratories and regenerative medicine infrastructure, Global CanCare helps hospitals and healthcare organisations establish advanced therapy programmes by connecting them with world-class expertise, technologies and trusted implementation partners.
Whether you're building a new programme or expanding existing capabilities, we help turn complex cell & gene therapy projects into clinically ready, future-focused healthcare solutions.
Who We Are
Building Advanced Cell & Gene Therapy Programmes for Modern Healthcare
Cell & gene therapy is transforming the treatment of cancer, rare diseases and genetic disorders - but delivering these therapies requires far more than clinical expertise alone.
Global CanCare works with hospitals, cancer centres, academic institutions and healthcare organisations to develop complete Cell & Gene Therapy programmes, combining infrastructure planning, GMP laboratory development, regulatory guidance, technology partnerships and implementation support under one simple, coordinated approach.
From early planning and feasibility studies to operational readiness, we help healthcare providers build programmes that are safe, compliant and designed for long-term clinical success.
Cell Therapy
Gene Therapy
CAR-T Therapy
GMP Cell Labs
Regenerative Medicine
SVF & PRP Therapy
Industry Snapshot
Cell & Gene Therapy Is Redefining the Future of Healthcare
Demand for personalised medicine, regenerative therapies and advanced cellular treatments is accelerating worldwide, creating unprecedented opportunities for healthcare organisations investing in next-generation clinical capabilities.
Powering the Future of Cell & Gene Therapy
USD 74.03B
Cell & Gene Therapy CDMO Market
projected to reach USD 74.03 billion by 2034, driven by increasing demand for advanced biologics and commercial-scale manufacturing.
Source: Precedence Research
2,130+
Active Clinical Trials
More than 2,130 active Cell & Gene Therapy clinical trials are underway worldwide, advancing innovation across oncology, regenerative medicine and rare diseases.
Source: Alliance for Regenerative Medicine
45+
FDA-Approved Therapies
The U.S. FDA has approved approximately 45 to 46 Cell & Gene Therapy products, including CAR-T therapies, gene therapies and treatments for rare diseases.
Source: U.S. FDA / Alliance for Regenerative Medicine
Advancing Innovation. Building Infrastructure. Transforming Lives.
Our Capabilities
End-to-End Cell & Gene Therapy Solutions
Cell Therapy Programme Development
Plan and establish comprehensive cell therapy programmes with support across clinical strategy, infrastructure planning, operational workflows and implementation - creating scalable services that are ready for clinical delivery.
Gene Therapy Solutions
Develop gene therapy programmes with access to specialist expertise in infrastructure planning, technology selection, regulatory pathways and clinical implementation tailored to your organisation's needs.
CAR-T Therapy Programme Development
Build successful CAR-T therapy programmes through coordinated planning, multidisciplinary workflow design and implementation support that enables safe, efficient patient care.
GMP Cell Processing Laboratories
Design and develop GMP-compliant Cell Processing Laboratories with optimised cleanroom layouts, validated workflows and quality systems that support advanced therapy manufacturing and regulatory compliance.
Regenerative Medicine Solutions
Expand into regenerative medicine with specialist guidance, innovative technologies and global expertise that help accelerate programme development and improve patient outcomes.
SVF Therapy Solutions
Support the development of Stromal Vascular Fraction (SVF) Therapy programmes through infrastructure planning, processing workflows, technology guidance and clinical implementation for regenerative medicine applications.
PRP Therapy Solutions
Establish Platelet-Rich Plasma (PRP) Therapy services with guidance on workflow optimisation, technology selection, clinical protocols and operational best practices across orthopaedics, sports medicine, wound care and aesthetic medicine.
Hospital Partnerships
Partner with hospitals, cancer centres, academic institutions and research organisations to develop scalable Cell & Gene Therapy capabilities through strategic collaborations, technology partnerships and clinical programme development.
Why Global CanCare?
Building Cell & Gene Therapy Programmes for the Future of Healthcare
Global CanCare combines international expertise, specialist technologies and integrated project delivery to help hospitals and healthcare organisations establish scalable Cell & Gene Therapy capabilities - from strategy and infrastructure to implementation and operational readiness.
Book a Free Consultation TodayGlobal Partner Network
Access to leading technology providers, clinical experts and advanced therapy specialists.
GMP & Regulatory Excellence
Infrastructure and quality systems designed to meet global GMP and regulatory standards.
Integrated Project Delivery
One partner coordinating planning, laboratories, technology, clinical workflows and implementation.
Designed for the Future
Infrastructure that supports CAR-T Therapy, Gene Therapy, Regenerative Medicine and the next generation of precision healthcare.
Global CanCare Ecosystem